ASCO 2021: Promising Data for a New Treatment Option of non-Hodgkin's Lymphoma

In this interview Paul Schmidt, co-host of The Onco'Zine Brief, asked Laurie H. Sehn, MD, Clinical Professor at the British Columbia Cancer Centre for Lymphoid Cancer in the Division of Medical Oncology at the University of British Columbia, Vancouver, BC, Canada, about new treatment options for patients diagnosed with non-Hodgkin's Lymphoma, presented at the 2021 Annual Meeting of the American Society of Clinical Oncology (ASCO).